# Glenmark Pharmaceuticals Limited, Chhatrapati Sambhajinagar, India – FDA Inspections

Source: https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/dacc6330-129c-4ce4-8c41-f71525daebe5

> Inspection records and compliance data for Glenmark Pharmaceuticals Limited in Chhatrapati Sambhajinagar. 7 FDA inspections on record, 1 Form 483, last inspected November 28, 2025.

---

## Details

- Name: Glenmark Pharmaceuticals Limited
- FEI Number: 3009915929
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: B-25 Midc Shendra
- City: Chhatrapati Sambhajinagar
- Country Name: India
- Address: B-25 Midc Shendra, Chhatrapati Sambhajinagar, India
- Country: India

## Related Documents

- FDA Inspection 1298220 - Glenmark Pharmaceuticals Limited - 2025-11-28 — source: FDA, date: November 28, 2025
- FDA Inspection 1252922 - Glenmark Pharmaceuticals Limited - 2024-09-20 — source: FDA, date: September 20, 2024
- FDA Inspection 1252922 - Glenmark Pharmaceuticals Limited - 2024-09-20 — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2024
- FDA Inspection 1226884 - Glenmark Pharmaceuticals Limited - 2023-12-15 — classification: No Action Indicated (NAI), source: FDA, date: December 15, 2023
- [483 - Glenmark Pharmaceuticals Limited - 2022-07-01](https://www.keypedia.com/records/483/glenmark-pharmaceuticals-limited/5c9b47bb-ce4e-4cf4-a78c-507c99cb05ab) — source: FDA, date: July 1, 2022
- [FDA Inspection 1122444 - Glenmark Pharmaceuticals Limited - 2020-02-21](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/7480abca-376a-48b0-8d6c-47a32ec70561) — classification: No Action Indicated (NAI), source: FDA, date: February 21, 2020
- [FDA Inspection 1065438 - Glenmark Pharmaceuticals Limited - 2018-08-17](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-limited/84e00ca0-c1d9-49f1-aa35-11332d0d7eec) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 17, 2018
- FDA Inspection 1025068 - Glenmark Pharmaceuticals Limited - 2017-07-21 — source: FDA, date: July 21, 2017
- FDA Inspection 978521 - Glenmark Pharmaceuticals Limited - 2016-06-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 17, 2016

## Related Companies

- [Watson Pharma Private Limited](https://www.keypedia.com/companies/watson-pharma-private-limited/846d9c2f-be10-415a-b681-5436e078ebfd)
- [AstraZeneca Nijmegen B.V.](https://www.keypedia.com/companies/astrazeneca-nijmegen-bv/29dc14a3-b8e5-4e0a-9399-8d18afc9d686)
- [Alphapharm Pty, Ltd.](https://www.keypedia.com/companies/alphapharm-pty-ltd/9007b3c5-9b83-4783-b65d-52eb0246708e)
- [Thymoorgan Pharmazie Gmbh](https://www.keypedia.com/companies/thymoorgan-pharmazie-gmbh/b58b84eb-57d4-4730-8fbb-58632f71023d)
- [Bora Pharmaceuticals Laboratories, Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-laboratories-inc/9bb86ed9-7d7d-4886-a145-b9497462c295)
- [Takeda GmbH, Plant Oranienburg](https://www.keypedia.com/companies/takeda-gmbh-plant-oranienburg/c72ad117-1d9b-474a-8d1a-c4d0e81e9ba8)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9)
- [Merck Serono S.p.A.](https://www.keypedia.com/companies/merck-serono-spa/052a4b09-0189-4f5c-bdcc-33182a7d3488)
- [IBSA Institut Biochimique SA](https://www.keypedia.com/companies/ibsa-institut-biochimique-sa/b4d0cf36-d7bc-4ea3-851a-9b0efe59255e)

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/rajiv-r-srivastava/05b42bfd-0cf4-42ce-89e1-b81bf36eaa17)